合霉素引致之再生障碍性贫血曾见于文献。我院新近收治一例因不规则应用合霉素引起再生障碍性贫血致死,报告于后。病例报告:住院号59966,女,25岁,医学生,于1963年12月11日因贫血月余入院。四月余前因患“痢疾”连续服用合霉素20克(10日),症状好转,一个月后,因“痢疾”复发,又连续服用合霉素20余日(共23.5克),大便次数减少,但一月余前,突起喉痛,高烧40℃,腹泻及脓血便, Amygdalacetin-induced aplastic anemia has been found in the literature. Our hospital recently admitted to a case due to irregular application of tetracycline caused by aplastic anemia, reported later. Case report: Inpatient number 59966, female, 25 years old, medical student, was admitted to hospital on December 11, 1963 due to anemia. In April, patients with “dysentery” continued to take 20 grams of doxorubicin (10 days) before the end of April. The symptoms improved. One month later, the patients were relapsed because of “dysentery” G), stool frequency decreased, but more than a month ago, sudden throat, high fever 40 ℃, diarrhea and pus and blood,